DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1Aarti Pharmalabs
03 1Acebright India Pharma Private Limited
04 1Apotex Pharmachem
05 1Archimica
06 1Cipla
07 1Divis Laboratories
08 1Hetero Drugs
09 2Intas Pharmaceuticals
10 1JIANGSU ZW PHARMACEUTICALS CO LTD
11 1Jiangsu Hengrui Medicine
12 1LIANYUNGANG GUIKE PHARMACEUTICAL
13 1MSN Laboratories
14 1Mac-Chem Products (India) Pvt.Ltd
15 2Qilu Tianhe Pharmaceutical Co., Ltd.
16 1Reliance Life Sciences Private Limited
17 1ScinoPharm Taiwan, Ltd
18 1Shilpa Medicare
19 1Sichuan Xieli Pharmaceutical
20 1Signa S.A. de C.V.
21 1Sun Pharmaceutical Industries Limited
22 1Teva API
23 1Vannsh Life Sciences
24 1Viatris
25 1Zhejiang Cheng Yi Pharmaceutical Co., Ltd
26 1Zhejiang Hisun Pharmaceutical
27 1Zydus Lifesciences
01 9CAPECITABINE
02 2CAPECITABINE (NON-STERILE API)
03 1CAPECITABINE (NON-STERILE, BULK FORM)
04 12CAPECITABINE USP
05 1CAPECITABINE USP (PROCESS II)
06 1CAPECITABINE USP [DRUG SUBSTANCE (NON-STERILE)]
07 1CAPECITABINE USP [ROUTE CODE - "CT"]
08 1CAPECITABINE USP, NON-STERILE, BULK DRUG SUBSTANCE
09 1CAPECITABINE, USP
01 1Canada
02 8China
03 15India
04 1Israel
05 1Italy
06 1Mexico
07 1Taiwan
08 1U.S.A
01 18Active
02 11Inactive
01 10Complete
02 19Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22479
Submission : 2009-01-30
Status : Active
Type : II
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22954
Submission : 2009-07-17
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-02-06
Pay. Date : 2016-09-09
DMF Number : 25054
Submission : 2011-06-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25266
Submission : 2011-09-07
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-04-28
Pay. Date : 2014-04-21
DMF Number : 22157
Submission : 2008-10-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-12-18
Pay. Date : 2013-06-21
DMF Number : 22140
Submission : 2008-10-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24370
Submission : 2010-11-09
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-09-14
Pay. Date : 2016-06-15
DMF Number : 23808
Submission : 2010-05-25
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-04-21
Pay. Date : 2013-09-23
DMF Number : 24126
Submission : 2010-08-31
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-07-07
Pay. Date : 2013-02-21
DMF Number : 24689
Submission : 2011-03-24
Status : Active
Type : II
We have 27 companies offering pentyl N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl}carbamate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?